Dimed SA Distribuidora do Medicamentos operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dimed SA Distribuidora do Medicamentos with three other
drug stores in Latin America:
Empreendimentos Pague Menos SA
(2020
sales of 6.89 billion Brazilian Reals [US$1.35 billion]
),
Farmacias Benavides S.A.B. de C.V.
of MEXICO
(13.87 billion Mexican Pesos [US$697.32 million]
), and
Profarma Distribuidora de Produtos Farmaceuticos SA
(5.48 billion Brazilian Reals [US$1.07 billion]
of which 96%
was Pharmaceutical Distribution).
Sales Analysis.
During the first
quarter of 2021, sales at Dimed SA Distribuidora do Medicamentos totalled
752.34 million Brazilian Reals.
This is
an increase of 8.6%
from the 692.96 million Brazilian Reals in sales at the company during the first quarter of 2020.
Sales at Dimed SA Distribuidora do Medicamentos appear to have some seasonality: during each of the previous 9
years, sales have been highest during the fourth quarter, which has accounted for
between 26.1% and 28.5%
of the annual
sales.
Dimed SA Distribuidora do Medicamentos reported sales of 2.82 billion Brazilian Reals (US$550.83 million)
for the
year ending
December of 2020.
This
represents
an
increase of 3.5%
versus 2019, when the company's sales were 2.72 billion Brazilian Reals.
Sales at Dimed SA Distribuidora do Medicamentos have increased during each of the previous five years
(and since 2015, sales have increased a total of 42%).
Sales of Retail saw an increase
of
5.1% in 2020, from
2.45 billion Brazilian Reals to 2.58 billion Brazilian Reals.
Not all segments of Dimed SA Distribuidora do Medicamentos experienced an increase in sales in 2020:
sales of Wholesale fell 11.2% to 240.31 million Brazilian Reals.